|
AP3S1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.77289999999864E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.734100E-02 |
| Normal-vs-Stage2 |
3.580300E-02 |
| Normal-vs-Stage3 |
1.354270E-04 |
| Normal-vs-Stage4 |
4.958800E-03 |
| Stage1-vs-Stage2 |
3.421600E-01 |
| Stage1-vs-Stage3 |
9.939800E-03 |
| Stage1-vs-Stage4 |
4.283800E-03 |
| Stage2-vs-Stage3 |
2.619400E-01 |
| Stage2-vs-Stage4 |
7.039800E-02 |
| Stage3-vs-Stage4 |
2.628800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.174500E-04 |
| Normal-vs-AfricanAmerican |
7.815700E-03 |
| Normal-vs-Asian |
6.349900E-02 |
| Caucasian-vs-AfricanAmerican |
7.949800E-01 |
| Caucasian-vs-Asian |
7.016900E-03 |
| AfricanAmerican-vs-Asian |
2.053800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.797600E-04 |
| Normal-vs-Female |
4.39629999999802E-05 |
| Male-vs-Female |
3.142400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.813790E-02 |
| Normal-vs-Extreme_Weight |
7.895700E-03 |
| Normal-vs-Obese |
1.402480E-02 |
| Normal-vs-Extreme_Obese |
7.812600E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.644800E-01 |
| Normal_Weight-vs-Obese |
6.827800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.160000E-01 |
| Extreme_Weight-vs-Obese |
7.083800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.746600E-01 |
| Obese-vs-Extreme_Obese |
3.749000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.117900E-03 |
| Normal-vs-Age(41-60Yrs) |
3.79769999999668E-05 |
| Normal-vs-Age(61-80Yrs) |
3.114300E-02 |
| Normal-vs-Age(81-100Yrs) |
4.682300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.075610E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.092340E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.459800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.837500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.501000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.334790E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.546000E-02 |
| Normal-VS-Type2 PRCC |
7.99740000000382E-05 |
| Normal-VS-KIRP CIMP |
4.352400E-04 |
| Normal-VS-Unclassified PRCC |
2.022000E-03 |
| Type1 PRCC-VS-Type2 PRCC |
4.377500E-03 |
| Type1 PRCC-VS-KIRP CIMP |
2.05789999485617E-08 |
| Type1 PRCC-VS-Unclassified PRCC |
2.882000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.124600E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
7.198400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.411400E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.299930E-02 |
| Normal-vs-N1 |
1.53063999999148E-05 |
| Normal-vs-N2 |
5.284000E-02 |
| N0-vs-N1 |
2.989800E-02 |
| N0-vs-N2 |
3.954200E-02 |
| N1-vs-N2 |
1.954360E-01 |
|
|
